Akorn (AKRX) to Restate Q1 Financials on Kilitch Drugs Accounting Issue
Tweet Send to a Friend
Akorn, Inc. (Nasdaq: AKRX), announced that it will restate the previously issued unaudited financial statements contained in its Quarterly Report ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE